Australia's largest stock trading and investment forum Australia's #1 stock forum

NEURIZON THERAPEUTICS LIMITED

3.13%

16.5¢

Market Cap $81.23M

Healthcare Biotechnology

Neurizon Therapeutics Limited (ASX: NUZ) is a clinical-stage biotechnology company... Neurizon Therapeutics Limited (ASX: NUZ) is a clinical-stage biotechnology company dedicated to advancing treatments for neurodegenerative diseases. Neurizon is developing its lead drug candidate, NUZ-001, for the treatment of ALS, which is the most common form of motor neurone disease. Neurizon's strategy is to accelerate access to effective ALS treatments for patients, while exploring NUZ-001’s potential for broader neurodegenerative applications.More

Corporate Spotlight

Neurizon Therapeutics Limited (ASX: NUZ) is a clinical-stage biotechnology company dedicated to advancing treatments for neurodegenerative diseases. Neurizon is developing its lead drug candidate, NUZ-001, for the treatment of ALS, which is the most common form of motor neurone disease.
View the full Corporate Spotlight

NUZ ADVANCES NUZ-001 & GLOBAL LICENSING AGREEMENT

Latest Threads

Tag

Subject

Ann: Positive feedback from FDA on strategy to lift clinical hold

21:41

44

10K

21:41

Last post 180*

44

10K

Ann: Neurizon Enters Global Licensing Agreement with Elanco

2 3

11:08

172

39K

11:08

Last post Quiltman

172

39K

NUZ -- New Investor thread

30 31 32

07:25

1.8K

594K

07:25

Last post NZ Trader

1.8K

594K

Pharmaust - Media & News

4 5 6

10/07/25

351

129K

10/07/25

Last post Densy

351

129K

Pharmaust brand name required

09/07/25

41

9.7K

09/07/25

Last post Jakjazz

41

9.7K

NUZ Perplexity Assessments

08/07/25

42

9.6K

08/07/25

Last post adreamer

42

9.6K

Ann: Presentation Materials - Licensing Agreement Webinar

06/07/25

22

5.4K

06/07/25

Last post Cashtrain

22

5.4K

NUZ TOP HOLDERS MOVEMENT REPORT 30 JUNE 2025

03/07/25

4

1.1K

03/07/25

Last post Captain Goodvybes

4

1.1K

NUZOA TOP HOLDERS REPORT 30 JUNE 2025

03/07/25

0

309

03/07/25

Last post RAN58

0

309

Ann: Invitation to Shareholder Webinar

02/07/25

0

528

02/07/25

Last post

ASX News

0

528

NUZ Charting Thread

01/07/25

32

10K

01/07/25

Last post Captain Goodvybes

32

10K

Ann: NUZ-001 Shows Promise in a Model of Huntington's Disease

2

29/06/25

75

22K

29/06/25

Last post illdrink2that

75

22K

Ann: Neurizon develops liquid formulation of NUZ-001

2

28/06/25

65

16K

28/06/25

Last post QuanQuest

65

16K

Ann: Notification regarding unquoted securities - NUZ

27/06/25

7

1.7K

27/06/25

Last post coads

7

1.7K

Ann: NUZ-001 Shows Significant Blood-Brain Barrier Penetration

25/06/25

58

16K

25/06/25

Last post Lastly

58

16K

Ann: NUZ-001 Promotes Survival in TDP-43 Challenged NSC-34 Cells

2

20/06/25

66

21K

20/06/25

Last post Van1

66

21K

See All Discussions

Corporate Spotlight

ABOUT NEURIZON

Timeline

Positive feedback from FDA on strategy to lift clinical hold
10 Jul 09:15	Share

Presentation Materials - Licensing Agreement Webinar
02 Jul 12:20	Share

Invitation to Shareholder Webinar
02 Jul 08:58	Share

Neurizon Enters Global Licensing Agreement with Elanco
02 Jul 08:49	Share

Notification regarding unquoted securities - NUZ
26 Jun 17:57	Share

Neurizon develops liquid formulation of NUZ-001
26 Jun 09:24	Share

NUZ-001 Shows Significant Blood-Brain Barrier Penetration
20 Jun 09:32	Share

Release of Securities from Escrow
16 Jun 19:12	Share

NUZ-001 Shows Promise in a Model of Huntington's Disease
16 Jun 09:32	Share

Change of Registered Office and Principal Place of Business
02 Jun 09:45	Share

Neurizon to present at Annual ALS Drug Development Summit
14 May 16:54	Share

Neurizon to present Q3 FY2025 Results
06 May 12:48	Share

Last Patient Successfully Completes Treatment in OLE Study
05 May 09:23	Share

Appendix 4C & Quarterly Update
28 Apr 09:11	Share

Notice of Quarterly Shareholder Update Webinar
24 Apr 09:28	Share

Appointment of Chief Financial Officer
22 Apr 09:28	Share

Leadership team strengthened with strategic appointments
17 Apr 09:22	Share

NUZ-001 Promotes Survival in TDP-43 Challenged NSC-34 Cells
04 Apr 12:07	Share

NUZ-001 Shows Positive Results in Human 3D Brain Model
01 Apr 09:03	Share

NUZ-001 shows promising respiratory outcome
24 Mar 09:47	Share

Neurizon Commences Initiatives to Lift Clinical Hold
17 Mar 09:22	Share

Appendix 4D - Half-year Financial Report - 31 December 2024
17 Feb 14:28	Share

Neurizon to Present Latest Results and Key Updates
17 Feb 09:27	Share

FDA Guidance on NUZ-001 IND Application
17 Feb 09:14	Share

Notice of Company Update Webinar
11 Feb 14:29	Share

Change of Director's Interest Notices x3
07 Feb 09:58	Share

US Patent granted for NUZ-001
05 Feb 09:18	Share

Notification regarding unquoted securities - NUZ
31 Jan 16:46	Share

Appendix 4C & Quarterly Update
29 Jan 09:14	Share

Neurizon updates on NUZ-001 IND Application
17 Jan 09:59	Share

Add to My Watchlist

What is My Watchlist?

A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.

(20min delay)
Last 16.5¢		Change 0.005(3.13%)		Mkt cap ! $81.23M

Open	High	Low	Value	Volume
16.5¢	16.5¢	15.5¢	$98.39K	606.6K

Buyers (Bids)

No.	Vol.	Price($)
1	3600	16.0¢

Sellers (Offers)

Price($)	Vol.	No.
16.5¢	86392	5

View Market Depth

No.	Vol.	Price($)
1	3600	0.160
9	233908	0.155
9	152547	0.150
2	303482	0.145
2	107135	0.140

Price($)	Vol.	No.
0.165	86392	5
0.170	473275	5
0.175	10000	1
0.180	71000	3
0.185	109375	3

Last trade - 15.45pm 11/07/2025 (20 minute delay)


Last 16.0¢			Change 0.005 ( 0.00 %)
Open	High		Low	Volume
16.0¢	16.5¢		15.5¢	372804
Last updated 15.23pm 11/07/2025 ?

NUZ (ASX) Chart

SPONSORED BY